SECTORS TODAY
Tech XLK -1.82%
Financials XLF +1.93%
Healthcare XLV -0.16%
Energy XLE -3.41%
Industrials XLI +1.53%
Cons. Disc. XLY +2.74%
Cons. Staples XLP +1.63%
Utilities XLU +0.71%
Materials XLB +1.97%
Real Estate XLRE +0.97%
Comm. Svcs XLC +0.99%

Earnings release · HPE

HPE reports fiscal 2026 third quarter results

Hewlett Packard Enterprise Co · Filed · SEC Form 8-K, Item 2.02

Hewlett Packard Enterprise Co company page Original on SEC.gov ↗

Revenue $12.2 billion +34% vs a year ago
EPS $0.08 not detected
Guidance raisedoutlook statement
Automated extract. The items below were picked out of the company's press release by software and may be wrong or incomplete. Please read the original before relying on any figure. Not investment advice.

Why it matters

Revenue increased 34% year on year to $12.2 billion, and EPS was $0.08. Management raised its outlook, and guidance changes often matter more to the market than the quarter just reported because they reflect expectations for the periods ahead.

Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.

What the company states

Revenue

$12.2 billion +34% vs a year ago

…Revenue: $12.2 billion, up 34% from the prior-year period…
EPS

$0.08

…net EPS estimate excludes net after-tax adjustments of approximately $0.08 per diluted share, primarily related to amortization of intangible as…
Guidance

Guidance raised

…“With our Q3 results and our order backlog at a record level, we are raising our financial outlook and plan to return at least 75% of free cash flow to shareholders in Q4.”. | HPE is raising its FY26 revenue growth outlook range to 34% to 37%.…

Read the original press release on SEC.gov ↗ Filing index ↗

Disclaimer: This page is generated automatically from public SEC filings for information only. Stocknote does not edit the company's release and does not guarantee the accuracy of the extracted items. Read the full disclaimer here.

Get new research in your inbox

Forensic equity research on US stocks. No spam, unsubscribe anytime.